+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
ID06803758

Testing Teicoplanin Allergy Using Patients Own Serum to Improve Skin Test Accuracy in Adults with Anaphylaxis During Anesthesia

Led by University Hospital Southampton NHS Foundation Trust · Updated on 2025-01-31

20

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating why allergy skin testing for Teicoplanin is less reliable compared to other similar drugs, which risks missing serious allergic reactions that can be life threatening. The study focuses on patients who have experienced anaphylaxis during general anesthesia where Teicoplanin was used. The goal is to find a better testing method to identify Teicoplanin allergies and improve patient safety. The trial involves 20 adult patients who experienced anaphylaxis during anesthesia and received Teicoplanin. In addition to the standard allergy skin test, researchers will perform extra skin tests using the patients own serum mixed with Teicoplanin. This autologous serum test is done during the same routine allergy appointment and aims to see if this method detects allergies more reliably than the usual skin test. Participants will undergo skin prick and intradermal testing with several sample types, including Teicoplanin mixed with blood before and after centrifugation and a serum control. Researchers will measure whether using autologous serum results in more positive allergy tests over two years. Throughout the study, safety and reaction monitoring will be conducted as part of the routine allergy evaluation process.

CONDITIONS

Brief Title

Teicoplanin Allergy Testing Using Autologous Serum (TATAS)

Research Team

L

Linda Nel, MB BCh FRCA

X

Xi Ying Soo, MBBS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here